Services

• Screening of hundreds of therapeutic antibodies for rapidly selecting the best candidates
• Precision information on the binding site of your antibodies
• Functional characterization of the epitope: identify the amino-acid residues required for antibody binding (these may include both antibody contact points and regions required for producing the "right" antigen conformation)
• Profiling of patients' sera for biomarker detection
• Profiling of vaccinees' sera for identification of the antigen regions targeted by the antibody response
• Epitope engineering to optimize structure-based vaccine development
• Selection of the best adjuvant to target the desired epitope
• Evaluation of protective effects of vaccine candidates, in in vivo and in vitro models
  
• Screening of B cell/plasmablast/hybridoma culture supernatants for finding clones with the desired epitope specificity in the early phases of monoclonal antibody production
• Quality control of vaccine batches